Genetic Association Mapping of Malaria Resistance in Anopheles Gambiae
NCT00850655 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2016-10-26
Summary
This is a study of the genetics of malaria transmission by the mosquito vector in Africa, Anopheles gambiae. The study focuses on the mosquito vector, not the human subjects infected with malaria. DNA extracted from infected mosquitoes will be analyzed genetically by microsatellite and single-nucleotide polymorphisms (SNPs) to identify mosquito genes that control mosquito resistance to malaria parasites.
Conditions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Kenneth D Vernick, PhD · University of Minnesota
Eligibility
- Min Age
- 5 Years
- Max Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-03-31
- Primary Completion
- 2015-03-31
- Completion
- 2015-03-31
Countries
- United States
Study Locations
More Related Trials
-
Controlled Human Malaria Infection After Bites From Mosquitoes Infected With Two Novel P. Falciparum Strains
NCT02149550 ·Status: COMPLETED ·Phase: NA
-
Malaria Genetic Surveillance
NCT03384498 ·Status: UNKNOWN
-
Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso
NCT04695197 ·Status: COMPLETED ·Phase: PHASE3
-
Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine
NCT05041556 ·Status: RECRUITING
-
In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure
NCT02590627 ·Status: COMPLETED ·Phase: PHASE4
-
Antimalarial Drug Resistance in Mali
NCT00127998 ·Status: COMPLETED ·Phase: NA
-
Artemether-lumefantrine Resistance Monitoring in Children With Uncomplicated Plasmodium Falciparum Malaria in Mali
NCT02645604 ·Status: COMPLETED
-
Efficacy of Antimalarial Drugs Used for the Treatment of Uncomplicated Malaria, Plasmodium Falciparum, at the Agadez, Gaya and Tessaoua Sentinel Sites
NCT05070520 ·Status: COMPLETED ·Phase: PHASE4
-
Combination Antimalarials in Uncomplicated Malaria
NCT00203801 ·Status: COMPLETED ·Phase: NA
-
Epidemiology Study of Malaria Transmission Intensity in Africa
NCT01190202 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria
NCT00709969 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Efficacy Study of AL and DP in Western Kenya
NCT05060198 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to Mosquitos
NCT02543086 ·Status: TERMINATED ·Phase: PHASE1
-
The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial Resistance
NCT00440752 ·Status: COMPLETED
-
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
NCT05750628 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)
NCT06294912 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar
NCT05025761 ·Status: UNKNOWN ·Phase: NA
-
A Study of Blood-stage Controlled Human Plasmodium Falciparum Malaria Infection in Tanzania
NCT04788862 ·Status: COMPLETED ·Phase: NA
-
Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
NCT02974348 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic
NCT02708199 ·Status: COMPLETED
-
Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in Mali
NCT05081089 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria
NCT05842954 ·Status: COMPLETED ·Phase: PHASE3
-
SP Resistance and Falciparum Malaria Transmission
NCT00299247 ·Status: WITHDRAWN ·Phase: PHASE3
-
Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in Children
NCT01082705 ·Status: COMPLETED ·Phase: PHASE3
-
Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites
NCT04310085 ·Status: COMPLETED ·Phase: PHASE1